Hwang, Phillip H, Leibel, Daniel, Popp, Zachary T, Drane, James, Lee, Marissa, Prabhu, Meha, Kohli, Anisha, Chen, Herbert, Kumar, Anupama, Lathan, Corinna, Au, Rhoda, and Vannorsdall, Tracy D
Background: The neurocognitive impact of having COVID is receiving greater awareness, with greater COVID severity potentially conferring risk of more negative cognitive outcomes. Current cognitive assessment methods are limited by factors, such as time and location, which can be mitigated by the use of mobile applications. We aimed to assess the relationship between COVID severity and cognitive performance at baseline and over time using a mobile cognitive assessment. Method: Participants in the analytic sample included 27 COVID‐positive (COVID+) Johns Hopkins Post‐acute Covid Team patients who received care in the intensive care unit (COVID+/ICU+; n = 6) or in other units (COVID+/ICU‐; n = 21). Another 23 participants from a separate study investigating the use of mobile cognitive applications in older adults were included as non‐COVID controls (COVID‐). Cognition was assessed via cognitive efficiency (CE) scores, a derived measure of speed and accuracy, for the Procedural Reaction Time (PRT) task of the Digital Automated Neurobehavioral Assessment (DANA) mobile application. Participants with missing or unavailable PRT assessment data were excluded from the analytic sample. PRT CE scores between COVID‐, COVID+/ICU‐, and COVID+/ICU+ participants were analyzed at baseline using ANOVA, as well as longitudinally over a six‐week period. Result: Table 1 presents demographic characteristics. At baseline, average PRT CE scores were highest among the COVID‐ group (mean = 86.55; standard deviation = 17.06), followed by the COVID+/ICU+ group (mean = 80.41; standard deviation = 15.83), and then the COVID+/ICU‐ group (mean = 76.93; standard deviation = 14.03). There was no significant difference in average baseline PRT CE scores between the three groups (p = 0.135). Those in the COVID‐ group and COVID+/ICU‐ group appeared to achieve higher PRT CE scores over the six‐week assessment period, while those in the COVID+/ICU+ group did not improve relative to their baseline (Figure 1a&b). Conclusion: We observed qualitative differences in the rate of recovery for cognitive performance between participants with COVID who did and did not require ICU admission. Given the limited sample size and other potential confounding factors, further analyses with additional data collected are needed in order to more rigorously compare cognitive performance cross‐sectionally and longitudinally between COVID groups. [ABSTRACT FROM AUTHOR]